Review Articles

2018  |  Vol: 4(4)  |  Issue: 4 (July- August)  |
Some promising medicinal plants with anti-diabetic wound healing activity: A review

Swathi Nair P.*, Gowtham M., Paridhavi M.

Department of Pharmaceutics, Rajiv Gandhi Institute of Pharmacy, Trikaripur, Kasaragod

Kerala, 671310, India

*Address for Corresponding Author

Swathi Nair P.

Department of Pharmaceutics, Rajiv Gandhi Institute of Pharmacy, Trikaripur, Kasaragod, Kerala, 671310, India


Diabetes mellitus (DM) is chronic disease of endocrine system and one of life threatening problems of the modern era, characterised by high level of glucose in blood. Diabetic patients have the enormous risk of serious infective foot ulcer or wound. The poor wound healing and ineffective functioning with infection in diabetic patient can cause gangrene and finally lead to limb amputation. Herbal medicine, also known as phytomedicine, have been widely used since the ancient times. Studies has been proved that the medicinal plants are rich sources of chemical substances with potential therapeutically and pharmacological activity for treatment of many diseases. Plant shows the presence of various life-sustaining constituents which have potential diabetic wound healing properties. Herbal preparation can be more effective than conventional medicines These phytomedicines are not only cheap and affordable but are also safe. Considering these facts the present review aims to reveal the up to date literature on recent ethnomedical uses with phytochemical review of two different medicinal plants Catharanthus roseus, Terminalia chebula which are commonly used for treatment diabetic wound healing in ayurvedic system of medicine.

Keywords: Diabetes mellitus (DM), Catharanthus roseus, Terminalia chebula


Diabetes mellitus is a chronic endocrine disorder, characterized by hyperglycaemia resulting from absolute or relative insulin deficiency. Uncontrolled diabetes can lead to a number of short and long-term health complications, including hypoglycemia, heart disease, nerve damage and amputation, and vision problems. Major increase in mortality of Diabetes is due to the development of both macro and micro vascular complication including failure of wound healing. Experts suggest that around 10 per cents of people with diabetes develop a foot ulcer at some point.

Foot ulcers can affect people with both type 1 and type 2 diabetes (Okonkwo and DiPietro, 2017). People with diabetes may have reduced nerve functioning due to peripheral diabetic neuropathy.

This means that the nerves that usually carries pain sensation to the brain from the feet do not function as well and it is possible for damage to occur our foot without feeling it (David and Greenhalgh, 2003). Treading on something, wearing tight shoes, cuts, blisters and bruises can all develop into diabetes foot ulcers. Narrowed arteries can also reduce blood flow to the feet amongst some people with diabetes and this can impair the foot’s ability to heal properly (Gowthamarajan et al., 2015). When the foot cannot heal, a foot ulcer can develop.

The aim  of this review is to provide information on the Phytochemicals, Ethnomedicinal uses and Pharmacological activities of two medicinal plants (Catheranthus roseus, Terminalia chebula) commonly used in Aurvedic medicine for the treatment of diabetes mellitus wound healing (Sharma et al., 2013).

Terminalia chebula

Figure 1. (a) Terminalia chebula fresh fruits (b) Terminalia chebula dried fruits


Terminalia chebula is a flowering deciduous tree of the family combrataceae. According to hindu mythology the plant is considered as it is originated from the drops of amrita so it is called king of medicines. The Terminalia consists of 250 species and widely distributed in tropical areas of the world (Rathinamoorthy and Thilagavathi, 2014).

Macroscopic character (Dodke and Pansare, 2017; Baliah and Astalakshmi, 2014)

Tree: medium to large sized highly branched deciduous tree with dark brown coloured steam having longitudinaly cracked woody scales. Stem is dark brown usually longitudinally cracked.

Leaves: Leaves is 10-30 cm long having alternative to sub opposite arrangement with broad petiole .6 to 8 pairs of veins are seen in each leaf let with an acute tip and cordate base.

Flower: flowers is dull white to yellowish colour and monecious in nature having strong unpleasant odour.                    

Fruits: The fruit is smooth ellipsoid to ovoid drupes, yellow to orange brown in colour and having  blackish, with five longitudinal ridges. Color yellowish, odour was characteristic and taste was found bitter.

Table 1. Taxonomic Classification (Singh and Malhotra, 2017)



Sub kingdom




Super division




Sub division




Super oder









Terminalia chebula

Table 2. Vernacular names of Terminalia chebula (Kumar and Kumar, 2017)






Harra, harad


Kayastha, jivapriya















Ethanomedical review

Terminalia chebula is one of the most commonly used plants in traditional systems of medicine in Indian sub continent and is also called “King of the medicine (Surya Prakash, et al., 2012) due to its wide range of phytochemical and pharmacological properties. The plant haritaki is an all rounder its one of the listed medicine in ayurvedic Meteria medica for the treatment of vomiting, gout, asthma, bleeding piles etc. it act as a natural laxative because it contain large amount of fibers. It also a welllknown blood purifier. As per thai medicine it act as carminative expectorant. Fruit extract posses anti cancer activity, antioxidant, cytoprotective activity, antispasmodic, cardiotonic activity and wound healing activity (Soni et al., 2013).

Fruits of Terminalia is used internally and externally of different purpose it is agreat wound healer in diabetic as well as normal wound it fastness the re epithelisation (Muhammad et al., 2012) and promote wound healing, and it have broad spectrum of anti bacterial activity. It is good for vision power, anti- aging, rejuvenative, and it improves life expectancy, nourishing, and the body weight.

Phytochemical review

Terminalia chebula contain several phytochemicals such as tannins fructose amino acids,resins flavonoids, sterols , but the major constituent is tannin approximately 32 percentage, the tannin contents varies according to the geographical locations. Phytochemicals like aminocaids fructose resins fixed oil, carbohydrates etc are also present in this plant, Terminalia chebula is a rich source of hydrolysable tannin like gallic acid, chebulic acid, punicalagin (Figure 2), chebulanin, corilagin, neochebulinic, ellagic acid, chebulagic acid, 1,2,3,4,6 -penta-orgalloyl-β-D-glucose 1,6-di-o-galloyl-D-glucose and Terchebulin. These are responsible for pharmacological activities. Phytochemicals like anthraquinone ethadioic acid, sennoside, 4.2.4-chebylyl-d-glycopyranose terpenes and terpinols have also been reported Some other minor chemical constituents were polyphenols such as corilagin, gallolyl glucose, punicalagin, terflavinA, maslimic acid. Fructose, amino acid, succinic acid, betasitosterol.

Figure 2. Major chemical constituents of Terminalia chebula





Anti-diabetic wound healing activity

Terminalia chebula were a potent source of antioxidative phenolic compounds that counteract with reactive oxygen species responsible for delayed wound healing. The fruits of Terminalia chebula significantly increased the level of superoxide dismutase, nitric oxide and decreased lipid peroxidation in granuloma tissue of diabetic mice. It promotes wound healing by reduction in blood glucose level, rapid contraction of wound area and increased granulation of tissue with elevated tensile strength.

Singh (2017) conducted a study on Terminalia chebula and summerise that the plant have a role in diabetic wound healing. Diabetic is induced on rat using streptozotocin. For the preparation of methanolic plant extract, soxhlet method was employed. Then the extract is subjected to phytochemical analysis. The extract shows the presence of alkaloid tannin, steroid, sapponins, flavanolid. A wound having 1 cm thickness was made in the mid-dorsum region of each rat and wound diameter is taken in 3d 7th and 13th day. Intraperitonial administration of methanolic extract of Terminalia chebula shows decrease in blood glucose level. When the dose was increases the hypoglycemic effect also increases. Study reveals that the hypoglycemic effect is due to the presence of secondary metabolites present in the plant such as flavonoid, terpenoid, tannins, phenolic compounds alkaloid etc. It helps in the regeneration of beta cells in the islets of Langerhans. Intreperitonial injection of extract accelerate the wound contraction in diabetic mice. The wound healing power is due to the presence of alkaloid tannins phenols which increases the epithelisation and collagen synthesis responsible for wound healing. Study says the herbal extract increase the amount of SOD and NO which stimulate the oxygen supply to the wound and accelerate the wound healing.

Singh (2009) conducted a study to determine the of wound healing potency of Terminalia chebula in diabetic rat. Alloxan is the chemical used to induce diabetic in rat. For this ethenolic extract were prepared using cold maceration process the , powdered  drug is soaked in 250 ml of hydroalchoholic solution(50%) for 2 day and the crude extract is used for the study. The excision and dead space wound models are employed to evaluate the diabetic wound healing potency of Terminalia chebula. For this study Sprague Dawely verity of rats are used. The wound healing property of Terminalia chebula seed extract with liquid paraffin ointment base is applied on the excision wound and the wound contraction is noted .mupirocin ointment was used as a standard. The study reveals that there is significant increase in the wound contraction in rat treated with extracts. The study says that the effective wound contraction is mainly due to presence of phytoconstituents such as phenols tannin and terpenoid. The study concluded that in excision and dead space wound model the wound closure is higher when compared to control group.

Catharanthus roseus

Figure 3. Flowers of Catharanthus roseus



Catharanthus roseus is an evergreens shrub of the family apocynaceae. There are 8 species (Das and Sharangi, 2017) of catheranthus, 7 species are endemic to Madagascar and one is endemic to india (C. pusillus). Catheranthus roseus have long history. The plant was traced by Mesopotominanns at 2600 bc. Based on the colour there are 2 main species Cartharanthus roseus having pink and Catharathus alba having white colour. C Roseus is the rich source of alkaloid so that the plant plays key role in world health care.

Macroscopic character (Goswami, 2016)

Plant: It is evergreen shrub having 1 m hight.

Leaves: Leaves is oval to oblongs, glossy green hairless, 2.5-9 cm long having opposite arrangement. Leaves powder showed green in color, odour was characteristic and taste was found bitter (Gilman and Howe, 1999).

Flowers (Tolambiya and Mathur, 2016): flowers are pink in colour with dark red at the center consist of 5 petals and having strong unpleasant odour.

Table 3.  Taxonomical Classification (Gilman and Howe, 1999)





Super division:





Magnoliopsida: dicotyledons












Catharanthus roseus

Table 4. Vernacular names of catharanthus roseus (Retna and Ethalsha, 2013)




Nithyakalyani, savakottapacha,Ushamalari








Bright-eyes, Cape periwinkle, graveyard plant,

Madagascar periwinkle, old-maid,


Sudukattu Mallikai




Sada-phul (Sadaphuli)





Ethanomedical review

Catharanthus roseus is well known plant for cancer treatment. The alkaloid, vincristine and vinblastine obtained from this plant acts by arresting mitosis the metaphase (Kokate  et al.,). It is given intravenously in the treatment of acute leukaemia of children. The plant extracts posses  anti diabetic, anti helminthic, anti oxidant anti diarrhoeal  properties. The roots of the plant was found to accumulate ajmalicine and serpentine, which are the important components of medicines that are used for controlling high blood pressure and other types of the cardio-vascular problems and it used in the treatment of  gastritis, cystitis, enteritis, memory loss, toothache, circulatory disorders, chest complaints, throat infections, Treats nose bleed, bleeding gums and haemorrhoids, eye infection and eye irritation (Nayak, 2006) and  Relieves symptoms of skin diseases such as acne, dermatitis and eczema  also Quickens healing process and stops bleeding (Sain and Sharma, 2013; Singh et al., 2014).

Phytochemical review

A large number of indole alkaloids is present in vinca. Out of themabout 20 dimeric (Sain and Sharma, 2013) indole dihydroindole alkaloid posesesses oncolytic activity, and among them,vincristine and vinblastine are most significant. Vinblastin contains indole alkaloid part called catharanthine and dihydroindole alkaloid part vindoline.The other alkaloid present in vinca is ajmaline, lochnerine,serpentine (Balaji, 2014), and tetrahydroalstonine. It requires about 500mg crude drug to extract out 1 g of vincristine, Because of its extreame low content ie.0002 per cent. This makes these alkaloids very costlier.

Figure 4. Major chemical constituents of Catharanthus roseus





Anti-diabetic wound healing activity

The wound-healing property of C. roseus may be attributed to the phytoconstituents present in the plant, and the quicker process of wound healing could be a function of either the individual or the additive effects of the phytoconstituents. Recent studies have shown that phytochemical constituents like flavonoids and tri-terpenoids are known to promote the wound-healing process mainly due to their astringent and antimicrobial properties which appear to be responsible for wound contraction and increased rate of epithelialisation.

Singh et al. (2014) examined the methanolic extract of leaves of Catharanthus roseus for antidiabetic wound healing activity. The diabetic wound healing property of Catharanthus roseus leaf are studied using excision wound model. The wound was inflicted by cutting 1 cm diameter of the skin on the mid- dorsum region of the rat and the wound contraction is observed during 1st, 7th and 13th day. In this study investigated that Catharanthus roseus accelerate wound healing and also reduces the blood sugar level. The study revealed  that the methanolic extract of l fresh leaves increases the  tensile strength, hydroxyproline content  in rats. The primary phytochemicical screening of leaves shows the presence of tannin alkaloid  and terpenoid the result revealed that these are the compound responsible for anti diabetic wound healing activity.

Nayak et al. (2006) studied antimicrobial and wound healing activity of flower extract of Catharanthus roseus in Sprague Dawley rats. Three wound models such as Excision, incision and dead space were used to assess the wound-healing activity of Catharanthus roseus flower extract. In excision wound model a wound having circular area of 300mm was made on the back of the animal, in the case of incision wound model. A longitudinal paravertebral incision, six centimetres in length was made through the skin and cutaneous muscle and all groups are treated with increasing concentration of extract. This study revealed that the plant have the potential to accelerate the wound healing and it increase the tensile strength and  hydroxyproline content in sparague dawly rats.

A study was conducted to determine Influence of Ethanol Extract of Vinca rosea on Wound Healing in Diabetic Rats. The diabetic wound healing property of Catharanthus roseus leaf extract (topical application) was studied using steptozotocin induced excision wound. Vasline was the control formulation. The rat was induced by diabetic using intraperitonial single dose injection of streptozotocin. Wound was created on the back having full thickness of 2.5 cm and depth of 0.2 cm. Leaves extract was applied for 10 days and wound contraction was measured during first fifth and leventh day using transparent marker. The phytochemical study of Catharanthus roseus revels that the extract has the presence of alkaloid tannin and triterpenoid. The study concluded that these are the compound responsible for diabetic wound healing. The study investigated that the plant has the capacity to increase the epithelisation and increase the blood flow and oxygen supply to the wound by blocking the vasoconstructive compounds.


Diabetes is the leading cause of nontraumatic lower extremity amputations in the world wide, with approximately 5% of diabetics developing foot ulcers each year and 1% requiring amputation. In this review article, an in depth study on ethnobotanical uses, phytochemical constituents and pharmacological activities of two major diabetic wound healing plants namely, Catheranthus roseas, Terminalia chebula have been done.

Nowadays, the demand for natural products and plant based medicines is growing throughout the world. Herbal preparation can be more effective than conventional medicines and their non-toxic nature means that they can be administrated over long period.


The authors express their sincere thanks to management and staffs of Rajiv Gandhi Institute of Pharmacy, Trikaripur, Kasaragod (Dist), Kerala, for giving all encouragement and valuable support to carry out this work.

Conflicts of interest: Nil


Balaji H. 2014. Versatile Therapeutic effects of Vinca rosea Linn. International Journal of Pharmaceutical Science and Health Care, 4(1):61-76.

David G, Greenhalgh MD. 2003. Wound healing and diabetes mellitus.Clinics in Plastic and Surgery, (30):37-45.

Dodke PC, Pansare TA. 2017. Ayurvedic and Modern aspect of Terminalia chebula Retz. Haritaki An Overview. International Journal of Ayurvedic & Herbal Medicine7(2):2508-2517.

Kuppusamy, Gowthamarajan S, Kumar MN, Malayandi R. 2015. Multiple Biological Actions of Curcumin in the Management of Diabetic Foot Ulcer Complications: A Systematic Review. Tropical Medicine & Surgery, 3(1):1-6.

Okonkwo UA, DiPietro LA. 2017. Diabetes and Wound Angiogenesis. International Journal of Molecular Sciences, 18(7):1-15.

Sharma YG, Singh JR, Semwal A. 2013. Current Aspects of Wound Healing Agent From Medicinal plant. Journal of Medicinal Plant Studies, 3(1):1-11.

Rathinamoorthy R, Thilagavathi G. 2014. Terminalia Chebula - Review on Pharmacological and Biochemical Studies.2014. International Journal of PharmTech Research, 6(1):97-116.

Baliah TN, Astalakshmi A. 2014. Phytochemical analysis and antibacterial activity of extracts from Terminalia chebula Retz. International Journal of Current Microbiology and Applied Sciences, 3(3):992-999.

Gilman EF, Howe T. 1999. Catharanthus roseus Periwinkle, Madagascar Periwinkle, Vinca. IFAS Extension publications.

Goswami S. 2016. Preliminary Phytochemical Screening and Standardisation of Leaves of Catharanthus roseus. Indian Journal of Research in Pharmacy and Biotechnology, 2320 – 3471.

Khan SMBA, Akhtar N, Mahmood T, Rasul A, Hussain I, Khan H, Badshah A. 2012. The morphology, extractions, chemical constituents and uses of Terminalia chebula: review. Journal of Medicinal Plants Research, 6(33): 4772-4775.

Kokate CK, Purohit AP, Gokhale SB. Text book of pharmacognosy. 7th Edition. Nirali publication, pp. 13.27-13.29.

Kumar A, Kumar S. 2017. Pharmacognostical and phytochemical evaluation of haritaki (terminaliachebula retz.) Fruit pulp. International Journal of Pharmaceutical, Chemical and Biological Sciences, 7(4):381-387.

Nayak S. 2006. Influence of ethanol extract of Vinca  rosea on wound healing in diabetic rat. Online Journal of Biological Science, 2(6):51-55.

Retna MA, Ethalsha P. 2013. A review of the taxonomy, ethanobotany,chemistry and pharmacology of Catheranthus roseus (Apocynaceae). International Journal of Engineering Research and Technology, 2(10):3899-3910.

Sain M, Sharma V. 2013. Catharanthus roseus (An anti-cancerousdrug yielding plant) - A Review of Potential Therapeutic Properties. International Journal of Pure & Applied Bioscience, 1(6):139-142.

Singh A, Singh PK, Singh RK. 2014. Antidiabetic and Wound Healing Activity of Catharanthus roseus L. in Streptozotocin-Induced Diabetic Mice. American Journal of Phytomedicine and Clinical Therapeutics, 2(6):686-692.

Singh P, Malhotra H. 2017. Terminalia chebula: a review pharmacognistic and phytochemical studies. International Journal of Recent Scientific Research,8(11):21496-21507.

Soni RN, Mehta M,  Srivastava DN. 2013. Healing potential of ethyl acetate soluble fraction of ethanolic extract of Terminalia chebula on experimental cutaneous wounds in streptozotocin induced diabetic rats. Asian Journal of Biomedical and Pharmaceutical Sciences, 3 (25): 32-36.

Surya Prakash DV, Sree Satya N, Avanigadda S, Vangalapati M. 2012. Pharmacological review on Terminalia chebula.  International Journal of Research in Pharmaceutical and Biomedical Sciences, 3(2):673-689.

Suddhasuchi Das, Sharangi AB. 2017. Madagascar periwinkle (Catharanthus roseus L.): Diverse medicinal and therapeutic benefits to Humankind. Journal of Pharmacognosy and Phytochemistry, 6(5): 1695-1701.

Tolambiya P, Mathur S. 2016. A Study on Potential Phytopharmaceuticals Assets in Catharanthus roseus. International Journal of Life Sciences Biotechnology and Pharma Research,5(1):1-6.

Upadhyay A, Agrahari P, Singh DK. 2018. A Review on the Pharmacological Aspects of Terminalia chebula. Science Alert, 1-10.

Manuscript Management System
Submit Article Subscribe Most Popular Articles Join as Reviewer Email Alerts Open Access
Our Another Journal
Another Journal
Call for Paper in Special Issue on

Call for Paper in Special Issue on